DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
SEPTEMBER 6-7, 1979 
Hie Recombinant ENA Advisory Committee (RAC) was convened for its sixteenth 
meeting at 9 a.m. on September 6, 1979, in Conference Room 10, Building 31, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland. 
Dr. Jane K. Setlcw, (Chairman) Biologist, Brookhaven National Laboratory 
presided. In accordance with Public Law 92-463 the meeting was open to 
the public, except for the review of proposals involving proprietary 
information as the last item of business on September 7, 1979. 
Committee members present for all or part of the meeting were : 
Dr. Abdul Karim Ahmed; Dr. David Baltimore; Dr. Winston Brill; Dr. Francis 
Broadbent; Dr. Allan Campbell; Mrs. Zelma Cason; Dr. Richard Goldstein; 
Dr. Susan Gottesman; Dr. Sheldon Krimsky; Dr. Werner Maas; Dr. James 
Mason; Dr. Elena Nightingale; Dr. Richard Novick; Dr. David Parkinson; 
Dr. Samuel Proctor; Mr. Ray Thornton; Dr. LeRoy Walters; Dr. Luther 
Williams; Dr. Frank Young; Dr. Milton Zaitlin; and Dr. William J. 
Gartland, Jr., Executive Secretary. 
A Committee roster is attached. (Attachment I) 
The following non-voting members and liaison representatives were present: 
Dr. Darryl Banks, Environmental Protection Agency; Mr. David Cannon, 
Department of Justice; Dr. George Duda, Department of Energy; Dr. George 
Gordon, Department of Commerce; Dr. Lor in Hatch, National Institute for 
Occupational Safety and Health; Dr. Timothy Henry, Pood and Drug 
Administration; Dr. Herman Lewis, National Science Foundation; Dr. Melvin 
Myers, National Institute for Occupational Safety and Health; Dr. Jane 
Schultz, Veterans Administration; and Dr. Sue Tolin, United States Department 
of Agriculture. 
Other National Institutes of Health staff present were : 
Dr. Stanley Barban, NICMS; Dr. W. Burnett Barkley, NCI; Mrs. Betty Butler, 
NIGMS; Dr. Irving Delappe, NIAID; Mr. David Harty, OGC; Dr. Steve Havas, 
NHLBI; Dr. John Irwin, DRS; Dr. Richard Krause, NIAID; Dr. Malcolm Martin, 
NIAID; Dr. Elizabeth Milewski, NIAID; Dr. Stanley Nagle, NIAID; Dr. John 
Nutter, NIAID; Mr. Richard Riseberg, OGC; Dr. Wallace Rowe, NIAID; and 
Dr. Bernard Talbot, OD. 
-*-The RAC is advisory to the NIH, and its recommendations should not be 
considered as final and accepted. The Office of Recombinant DNA Activities 
(ORDA) should be consulted for NIH policy on specific issues. 
[ 150 ] 
